| Year |
Citation |
Score |
| 2022 |
Kendrick JB, Zhou M, Ficociello LH, Parameswaran V, Mullon C, Anger MS, Coyne DW. Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary Cohort. International Journal of Nephrology and Renovascular Disease. 15: 139-149. PMID 35431567 DOI: 10.2147/IJNRD.S353213 |
0.317 |
|
| 2021 |
Vervloet MG, Boletis IN, de Francisco ALM, Kalra PA, Ketteler M, Messa P, Stauss-Grabo M, Derlet A, Walpen S, Perrin A, Ficociello LH, Rottembourg J, Wanner C, Cannata-Andía JB, Fouque D. Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study. Clinical Kidney Journal. 14: 1770-1779. PMID 34221384 DOI: 10.1093/ckj/sfaa211 |
0.353 |
|
| 2021 |
Zhou M, Ficociello LH, Mullon C, Mooney A, Williamson D, Anger MS. Real-World Performance of High-Flux Dialyzers in Patients With Hypoalbuminemia. Asaio Journal (American Society For Artificial Internal Organs : 1992). PMID 34172639 DOI: 10.1097/MAT.0000000000001511 |
0.346 |
|
| 2021 |
Zhou M, Ficociello LH, Mullon C, Mooney A, Williamson D, Anger MS. Real-World Performance of High-Flux Dialyzers in Patients With Hypoalbuminemia. Asaio Journal (American Society For Artificial Internal Organs : 1992). PMID 34172639 DOI: 10.1097/MAT.0000000000001511 |
0.346 |
|
| 2021 |
Kalantar-Zadeh K, Ficociello LH, Bazzanella J, Mullon C, Anger MS. Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis. International Journal of Nephrology and Renovascular Disease. 14: 11-21. PMID 33505168 DOI: 10.2147/IJNRD.S291348 |
0.325 |
|
| 2020 |
Coyne DW, Ficociello LH, Parameswaran V, Rosen MM, Mullon C, Kossmann RJ, Sprague SM. Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort Study. Kidney Medicine. 2: 307-316. PMID 32734250 DOI: 10.1016/j.xkme.2020.01.009 |
0.383 |
|
| 2020 |
Molony DA, Parameswaran V, Ficociello LH, Mullon C, Kossmann RJ. Sucroferric Oxyhydroxide as Part of Combination Phosphate Binder Therapy among Hemodialysis Patients Kidney. 1: 263-272. DOI: 10.34067/Kid.0000332019 |
0.401 |
|
| 2019 |
Kalantar-Zadeh K, Ficociello LH, Parameswaran V, Athienites NV, Mullon C, Kossmann RJ, Coyne DW. Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study. Bmc Nephrology. 20: 396. PMID 31664928 DOI: 10.1186/S12882-019-1582-9 |
0.377 |
|
| 2019 |
Gray K, Ficociello LH, Hunt AE, Mullon C, Brunelli SM. Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide. International Journal of Nephrology and Renovascular Disease. 12: 1-8. PMID 30774412 DOI: 10.2147/Ijnrd.S182747 |
0.432 |
|
| 2019 |
Kendrick J, Parameswaran V, Ficociello LH, Ofsthun NJ, Davis S, Mullon C, Kossmann RJ, Kalantar-Zadeh K. One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. PMID 30679076 DOI: 10.1053/J.Jrn.2018.11.002 |
0.422 |
|
| 2019 |
Kalra P, Fouque D, Francisco AD, Vervloet M, Ketteler M, Messa P, Stauss-Grabo M, Derlet A, Walpen S, Perrin A, Ficociello L, Rottembourg J, Cannata-Andia J, Wanner C, Boletis I. Fc024Real-World Safety And Effectiveness Of Sucroferric Oxyhydroxide In Patients Undergoing Peritoneal Dialysis: An Interim Analysis Of The Verifie Study Nephrology Dialysis Transplantation. 34. DOI: 10.1093/Ndt/Gfz096.Fc024 |
0.372 |
|
| 2018 |
Raimann JG, Ficociello LH, Usvyat LA, Zhang H, Pacelli L, Moore S, Sheppard P, Xiao Q, Wang Y, Mullon C, Balter P, Sullivan T, Kotanko P. Effects of dialysate to serum sodium (Na) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement project. Bmc Nephrology. 19: 75. PMID 29609536 DOI: 10.1186/S12882-018-0870-0 |
0.342 |
|
| 2018 |
Kalantar-Zadeh K, Parameswaran V, Ficociello LH, Anderson L, Ofsthun NJ, Kwoh C, Mullon C, Kossmann RJ, Coyne DW. Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide. American Journal of Nephrology. 47: 153-161. PMID 29514139 DOI: 10.1159/000487856 |
0.398 |
|
| 2018 |
Fouque D, Boletis I, Francisco Ad, Vervloet M, Kalra P, Ketteler M, Messa P, Stauss-Grabo M, Derlet A, Rakov V, Walpen S, Perrin A, Ficociello L, Rottembourg J, Cannata-Andia J, et al. Fp593Real-World Safety And Effectiveness Of Sucroferric Oxyhydroxide In Dialysis Patients: An Interim Analysis Of The Verifie Study Nephrology Dialysis Transplantation. 33. DOI: 10.1093/Ndt/Gfy104.Fp593 |
0.359 |
|
| 2018 |
Francisco Ad, Fouque D, Boletis I, Vervloet M, Kalra P, Ketteler M, Messa P, Stauss-Grabo M, Derlet A, Rakov V, Walpen S, Perrin A, Ficociello L, Cannata-Andia J, Wanner C, et al. Fo047Real-World Effectiveness Of Sucroferric Oxyhydroxide For Serum Phosphorus Control In Dialysis Patients: An Interim Subgroup Analysis Of The Verifie Study Nephrology Dialysis Transplantation. 33. DOI: 10.1093/Ndt/Gfy104.Fo047 |
0.431 |
|
| 2017 |
Coyne DW, Ficociello LH, Parameswaran V, Anderson L, Vemula S, Ofsthun NJ, Mullon C, Maddux FW, Kossmann RJ, Sprague SM. Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data
. Clinical Nephrology. PMID 28587714 DOI: 10.5414/Cn109021 |
0.487 |
|
| 2016 |
Ficociello LH, Parameswaran V, Mullon C, Ofsthun NJ, Zandt CV, Maddux FW, Kossmann RJ. Mp575Serum Phosphorus And Phosphate Binder Pill Burden In Diabetic Hemodialysis Patients Switched To Sucroferric Oxyhydroxide As Part Of Routine Care Nephrology Dialysis Transplantation. 31. DOI: 10.1093/Ndt/Gfw197.10 |
0.452 |
|
| 2015 |
Brunelli SM, Wilson SM, Ficociello LH, Mullon C, Diaz-Buxo JA. A Comparison ofClinical Parameters and Outcomes Over 1 Year in Home Hemodialysis Patients Using 2008K@home™ or NxStage® System One™. Asaio Journal (American Society For Artificial Internal Organs : 1992). PMID 26692402 DOI: 10.1097/Mat.0000000000000315 |
0.32 |
|
| 2015 |
Orlov S, Cherney DZ, Pop-Busui R, Lovblom LE, Ficociello LH, Smiles AM, Warram JH, Krolewski AS, Perkins BA. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 10: 1136-44. PMID 26092828 DOI: 10.2215/Cjn.11441114 |
0.544 |
|
| 2014 |
Sibbel SP, Ficociello LH, Black M, Thakuria M, Mullon C, Diaz-Buxo J, Alfieri TJ. Effects of Crit-Line® monitor use on patient outcomes and epoetin alfa dosing following onset of hemodialysis: a propensity score-matched study. Blood Purification. 37: 249-57. PMID 24970017 DOI: 10.1159/000362107 |
0.389 |
|
| 2013 |
Merchant ML, Niewczas MA, Ficociello LH, Lukenbill JA, Wilkey DW, Li M, Khundmiri SJ, Warram JH, Krolewski AS, Klein JB. Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. Kidney International. 83: 1177-84. PMID 23466993 DOI: 10.1038/Ki.2013.8 |
0.585 |
|
| 2012 |
Perkins BA, Rabbani N, Weston A, Ficociello LH, Adaikalakoteswari A, Niewczas M, Warram J, Krolewski AS, Thornalley P. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. Plos One. 7: e35655. PMID 22558190 DOI: 10.1371/Journal.Pone.0035655 |
0.523 |
|
| 2012 |
Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. Journal of the American Society of Nephrology : Jasn. 23: 516-24. PMID 22266664 DOI: 10.1681/Asn.2011060628 |
0.605 |
|
| 2011 |
Schoenfeld DA, Rajicic N, Ficociello LH, Finkelstein DM. A test for the relationship between a time-varying marker and both recovery and progression with missing data. Statistics in Medicine. 30: 718-24. PMID 21394748 DOI: 10.1002/Sim.4145 |
0.428 |
|
| 2011 |
Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney International. 79: 464-70. PMID 20980978 DOI: 10.1038/Ki.2010.404 |
0.549 |
|
| 2010 |
Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care. 33: 1337-43. PMID 20332356 DOI: 10.2337/Dc10-0227 |
0.659 |
|
| 2010 |
Perkins BA, Ficociello LH, Roshan B, Warram JH, Krolewski AS. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney International. 77: 57-64. PMID 19847154 DOI: 10.1038/Ki.2009.399 |
0.563 |
|
| 2010 |
Finkelstein DM, Wang R, Ficociello LH, Schoenfeld DA. A score test for association of a longitudinal marker and an event with missing data. Biometrics. 66: 726-32. PMID 19754923 DOI: 10.1111/J.1541-0420.2009.01326.X |
0.355 |
|
| 2009 |
Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS, Klein JB. Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. Journal of the American Society of Nephrology : Jasn. 20: 2065-74. PMID 19643930 DOI: 10.1681/Asn.2008121233 |
0.559 |
|
| 2009 |
Ficociello LH, Perkins BA, Roshan B, Weinberg JM, Aschengrau A, Warram JH, Krolewski AS. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care. 32: 889-93. PMID 19196883 DOI: 10.2337/Dc08-1560 |
0.659 |
|
| 2009 |
Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, Warram JH, Krolewski AS. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 4: 62-70. PMID 19073786 DOI: 10.2215/Cjn.03010608 |
0.534 |
|
| 2008 |
Rosolowsky ET, Niewczas MA, Ficociello LH, Perkins BA, Warram JH, Krolewski AS. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Research and Clinical Practice. 82: S46-53. PMID 18849087 DOI: 10.1016/J.Diabres.2008.09.018 |
0.537 |
|
| 2008 |
Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, Warram JH, Krolewski AS. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 3: 706-13. PMID 18272826 DOI: 10.2215/Cjn.04271007 |
0.603 |
|
| 2008 |
Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. Journal of the American Society of Nephrology : Jasn. 19: 789-97. PMID 18256362 DOI: 10.1681/Asn.2007050556 |
0.52 |
|
| 2007 |
Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 461-9. PMID 17699452 DOI: 10.2215/Cjn.03691106 |
0.65 |
|
| 2007 |
Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, Krolewski AS. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. Journal of the American Society of Nephrology : Jasn. 18: 1353-61. PMID 17329575 DOI: 10.1681/Asn.2006080872 |
0.504 |
|
| 2003 |
Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. The New England Journal of Medicine. 348: 2285-93. PMID 12788992 DOI: 10.1056/Nejmoa021835 |
0.547 |
|
| Show low-probability matches. |